Literature DB >> 6188071

The behavioural effects of intrathecally administered [D-PRO2, D-TRP7,9]-substance P, an analogue with presumed antagonist actions, in the rat.

R E Rodriguez, T E Salt, P M Cahusac, R G Hill.   

Abstract

[D-Pro2, D-Trp7,9]-substance P, an analogue of the putative nociceptive primary afferent neurotransmitter substance P, was administered to rats via chronically implanted intrathecal catheters (0.5-2.5 nmol per rat). Several animals showed large elevations of thermal and mechanical nociceptive thresholds, but these effects were always accompanied by profound, often long-lasting, impairments of motor function and thus cannot be regarded as a specific antinociceptive effect of the drug. These behavioural effects are considered to be probably due to direct spinal actions of the drug rather than antagonism of spinal substance P systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188071     DOI: 10.1016/0028-3908(83)90005-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.

Authors:  J Freedman; T Hökfelt; G Jonsson; C Post
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

2.  Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone.

Authors:  J Freedman; T Hökfelt; C Post; E Brodin; E Sundström; G Jonsson; L Terenius; S Leander; J A Fischer; A Verhofstad
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.

Authors:  T Sakurada; Y Manome; K Tan-No; S Sakurada; K Kisara
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.

Authors:  N M Rupniak; S Boyce; A R Williams; G Cook; J Longmore; G R Seabrook; M Caeser; S D Iversen; R G Hill
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

5.  Desensitization to substance P following intrathecal injection. A technique for investigating the role of substance P in nociception.

Authors:  J Sawynok; G Robertson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Autonomic, sensory, and motor dysfunction following intrathecal administration of three substance P antagonists.

Authors:  B F Cox; R L Schelper; F M Faraci; M J Brody
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

7.  Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.

Authors:  S M Moochhala; J Sawynok
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.